326 related articles for article (PubMed ID: 35873153)
1. Advancing Key Gaps in the Knowledge of
Aparici Herraiz I; Caires HR; Castillo-Fernández Ó; Sima N; Méndez-Mora L; Risueño RM; Sattabongkot J; Roobsoong W; Hernández-Machado A; Fernandez-Becerra C; Barrias CC; Del Portillo HA
Front Cell Infect Microbiol; 2022; 12():920204. PubMed ID: 35873153
[No Abstract] [Full Text] [Related]
2. Cryptic erythrocytic infections in Plasmodium vivax, another challenge to its elimination.
Fernandez-Becerra C; Aparici-Herraiz I; Del Portillo HA
Parasitol Int; 2022 Apr; 87():102527. PubMed ID: 34896615
[TBL] [Abstract][Full Text] [Related]
3. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite.
Mueller I; Galinski MR; Baird JK; Carlton JM; Kochar DK; Alonso PL; del Portillo HA
Lancet Infect Dis; 2009 Sep; 9(9):555-66. PubMed ID: 19695492
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium vivax - How hidden reservoirs hinder global malaria elimination.
Angrisano F; Robinson LJ
Parasitol Int; 2022 Apr; 87():102526. PubMed ID: 34896312
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax pre-erythrocytic vaccines.
Reyes-Sandoval A
Parasitol Int; 2021 Oct; 84():102411. PubMed ID: 34166786
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
[TBL] [Abstract][Full Text] [Related]
7. Update on pathogenesis, management, and control of Plasmodium vivax.
Khan N; Daily JP
Curr Opin Infect Dis; 2022 Oct; 35(5):404-409. PubMed ID: 36066361
[TBL] [Abstract][Full Text] [Related]
8. Advancing Research Models and Technologies to Overcome Biological Barriers to Plasmodium vivax Control.
Armistead JS; Adams JH
Trends Parasitol; 2018 Feb; 34(2):114-126. PubMed ID: 29153587
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, drug resistance, and pathophysiology of
Dayananda KK; Achur RN; Gowda DC
J Vector Borne Dis; 2018; 55(1):1-8. PubMed ID: 29916441
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium vivax in Hematopoietic Niches: Hidden and Dangerous.
Silva-Filho JL; Lacerda MVG; Recker M; Wassmer SC; Marti M; Costa FTM
Trends Parasitol; 2020 May; 36(5):447-458. PubMed ID: 32298632
[TBL] [Abstract][Full Text] [Related]
11. Biological concepts in recurrent Plasmodium vivax malaria.
Markus MB
Parasitology; 2018 Nov; 145(13):1765-1771. PubMed ID: 29564998
[TBL] [Abstract][Full Text] [Related]
12. Development of vaccines for Plasmodium vivax malaria.
Mueller I; Shakri AR; Chitnis CE
Vaccine; 2015 Dec; 33(52):7489-95. PubMed ID: 26428453
[TBL] [Abstract][Full Text] [Related]
13.
Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
[No Abstract] [Full Text] [Related]
14. Plasmodium vivax vaccine research - we've only just begun.
Tham WH; Beeson JG; Rayner JC
Int J Parasitol; 2017 Feb; 47(2-3):111-118. PubMed ID: 27899329
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium vivax malaria vaccines: why are we where we are?
Reyes-Sandoval A; Bachmann MF
Hum Vaccin Immunother; 2013 Dec; 9(12):2558-65. PubMed ID: 23978931
[TBL] [Abstract][Full Text] [Related]
16. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
17. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
Wells TN; Burrows JN; Baird JK
Trends Parasitol; 2010 Mar; 26(3):145-51. PubMed ID: 20133198
[TBL] [Abstract][Full Text] [Related]
18. Cryptic Plasmodium chronic infections: was Maurizio Ascoli right?
Monteiro W; Brito-Sousa JD; Elizalde-Torrent A; Bôtto-Menezes C; Melo GC; Fernandez-Becerra C; Lacerda M; Del Portillo HA
Malar J; 2020 Nov; 19(1):440. PubMed ID: 33256745
[TBL] [Abstract][Full Text] [Related]
19. Antimalarials for children with Plasmodium vivax infection: Current status, challenges, and research priorities.
Woon SA; Manning L; Moore BR
Parasitol Int; 2022 Apr; 87():102512. PubMed ID: 34785369
[TBL] [Abstract][Full Text] [Related]
20. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
